We are live on ! Find out more
JAFL

Jay A. Fishman Ltd Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.75%
This Fund
S&P 500
This Quarter Est. Return
-5.24%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$691M
AUM Growth
-$42.5M
Cap. Flow
+$623K
Cap. Flow %
0.09%
Top 10 Hldgs %
67.18%
Holding
92
New
3
Increased
20
Reduced
28
Closed
2

Sector Composition

1 Technology 30.54%
2 Healthcare 15.2%
3 Financials 14.28%
4 Industrials 12.47%
5 Consumer Discretionary 11.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
76
NVIDIA
NVDA
$5.02T
$366K 0.05%
30,140
+13,000
+76% +$206K
IBB icon
77
iShares Biotechnology ETF
IBB
$9.22B
$344K 0.05%
2,940
PEP icon
78
PepsiCo
PEP
$190B
$335K 0.05%
2,050
-373
-15% -$64.3K
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$305K 0.04%
855
EXR icon
80
Extra Space Storage
EXR
$31.8B
$302K 0.04%
1,750
INTU icon
81
Intuit
INTU
$80.6B
$284K 0.04%
732
MSCI icon
82
MSCI
MSCI
$46.4B
$238K 0.03%
565
MAR icon
83
Marriott International
MAR
$97.9B
$238K 0.03%
1,700
PG icon
84
Procter & Gamble
PG
$353B
$224K 0.03%
1,775
IEMG icon
85
iShares Core MSCI Emerging Markets ETF
IEMG
$151B
$217K 0.03%
5,050
-900
-15% -$43.1K
SHYF
86
DELISTED
The Shyft Group
SHYF
$204K 0.03%
10,000
GOEV
87
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$192K 0.03%
223
PMVP icon
88
PMV Pharmaceuticals
PMVP
$69.3M
$119K 0.02%
+10,000
New +$144K
TYRA icon
89
Tyra Biosciences
TYRA
$1.88B
$92.3K 0.01%
+10,500
New +$96K
IBRX icon
90
ImmunityBio
IBRX
$7.8B
$49.7K 0.01%
+10,000
New +$45.6K
GS icon
91
Goldman Sachs
GS
$323B
-770
Closed -$229K
OTIS icon
92
Otis Worldwide
OTIS
$28.8B
-3,195
Closed -$226K

Similar funds

Jay A. Fishman Ltd's Q3 2022 Portfolio in Review

As of Q3 2022, Jay A. Fishman Ltd held 92 positions worth $691M, down 5.8% from $734M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Jay A. Fishman Ltd's Q3 2022 filing shows 3 new, 20 increased, 28 reduced and 2 closed positions. Its largest new stake was PMV Pharmaceuticals: 10,000 shares worth $119K. The largest sale was Meta Platforms (Facebook), an estimated $2.08M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Jay A. Fishman Ltd's largest Q3 2022 buy was PMV Pharmaceuticals: 10,000 shares worth $119K.
  • Jay A. Fishman Ltd added most to Amazon in Q3 2022, an estimated $1.44M increase.
  • Jay A. Fishman Ltd's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.08M.
  • Jay A. Fishman Ltd fully exited Goldman Sachs in Q3 2022, selling an estimated $229K.
  • Jay A. Fishman Ltd's ten largest holdings make up 67% of its $691M portfolio in Q3 2022.
  • Jay A. Fishman Ltd opened 3 new positions and closed 2 in Q3 2022.
  • Jay A. Fishman Ltd's portfolio value fell 5.8% quarter-over-quarter to $691M.

Based on Jay A. Fishman Ltd's 13F filing for Q3 2022, filed 26 Oct 2022.